Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine hydrochloride tablets plus standard treatment for pediatric COVID-19
ChiCTR2000033774Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bromhexine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Rate of aggravation. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000033774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033774.